Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:00378069n
Noun Concept
Categories: RTT, Hoffmann-La Roche brands, Specialty drugs, Monoclonal antibodies for tumors, Drugs that are a monoclonal antibody
EN
rituximab  AntiCD20  ATC code L01XC02  ATCvet code QL01XC02  Blitzima
EN
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. Wikipedia
Definitions
Relations
Sources
EN
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. Wikipedia
A monoclonal antibody used in the treatment of leukemia, lymphomas, transplant rejection and autoimmune disorders Wikipedia Disambiguation
IS A
compound
medicine
monoclonal antibody
essential medicines
biopharmaceutical
HAS PART
carbon
MEDICAL CONDITION TREATED
arthritis
leukemia
chronic lymphocytic leukemia
multiple sclerosis
interstitial pneumonia
+25 relations
SUBJECT HAS ROLE
disease-modifying antirheumatic drug
Wikipedia
EN
rituximab
Wikidata
EN
rituximab
Wikipedia Redirections
EN
ATC code L01XC02, ATCvet code QL01XC02, Blitzima, MabThera, MabThera SC, Riabni, Ritemvia, Rituxan, Rituxan Hycela, rituximab-abbs, rituximab-arrx, rituximab-pvvr, rituximab/hyaluronidase, Rituximab and hyaluronidase human, Rituximab hyaluronidase, Rituxin, Rituzena, Rixathon, Riximyo, Ruxience, Truxima
Wikidata Alias
EN
AntiCD20, IDEC-102, IDEC-C2B8, Ig gamma-1 chain C region, Mabthera Rituxan, R-105 IDEC-102, RG-105, rituxan

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License